Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,932 | 355 | 99.3% |
| Education | $68.99 | 1 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,836 | 101 | $0 (2024) |
| Organogenesis Inc. | $1,134 | 84 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $869.36 | 18 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $793.82 | 12 | $0 (2024) |
| GENZYME CORPORATION | $638.70 | 16 | $0 (2024) |
| PFIZER INC. | $494.53 | 21 | $0 (2024) |
| Janssen Biotech, Inc. | $389.95 | 21 | $0 (2024) |
| Lilly USA, LLC | $314.42 | 10 | $0 (2021) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $305.86 | 9 | $0 (2024) |
| Galderma Laboratories, L.P. | $249.38 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,366 | 122 | Organogenesis Inc. ($748.74) |
| 2023 | $1,642 | 85 | AbbVie Inc. ($506.48) |
| 2022 | $311.16 | 16 | ABBVIE INC. ($122.46) |
| 2021 | $608.08 | 25 | AbbVie Inc. ($361.70) |
| 2020 | $743.62 | 21 | AbbVie Inc. ($392.58) |
| 2019 | $2,241 | 49 | AbbVie, Inc. ($634.78) |
| 2018 | $1,960 | 36 | Novartis Pharmaceuticals Corporation ($402.03) |
| 2017 | $129.92 | 2 | Novartis Pharmaceuticals Corporation ($129.92) |
All Payment Transactions
356 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $28.11 | General |
| Category: Dermatology | ||||||
| 12/20/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $1.37 | General |
| Category: Dermatology | ||||||
| 12/13/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $32.96 | General |
| Category: IMMUNOLOGY | ||||||
| 12/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $27.51 | General |
| Category: Immunology | ||||||
| 12/10/2024 | Organogenesis Inc. | NOVACHOR (Medical Supply) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: WOUND CARE | ||||||
| 11/15/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $22.80 | General |
| Category: Immunology | ||||||
| 11/12/2024 | Organogenesis Inc. | CYGNUS DUAL (Medical Supply) | Food and Beverage | In-kind items and services | $24.84 | General |
| Category: WOUND CARE | ||||||
| 11/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $10.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/10/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $15.63 | General |
| 11/07/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Dermatology | ||||||
| 11/06/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $23.57 | General |
| Category: Inflammation & Immunology | ||||||
| 11/05/2024 | Helsinn Therapeutics (U.S.), Inc. | VALCHLOR (Drug) | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: ONCOLOGY | ||||||
| 11/04/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $27.05 | General |
| Category: IMMUNOLOGY | ||||||
| 11/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $8.16 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $18.38 | General |
| Category: DERMATOLOGY | ||||||
| 10/29/2024 | Organogenesis Inc. | MATRIX (Medical Supply) | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: WOUND CARE | ||||||
| 10/25/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: Dermatology | ||||||
| 10/22/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $37.15 | General |
| Category: Immunology | ||||||
| 10/22/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $7.54 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $12.68 | General |
| 10/15/2024 | Organogenesis Inc. | NOVACHOR (Medical Supply) | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: WOUND CARE | ||||||
| 10/14/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $23.46 | General |
| Category: IMMUNOLOGY | ||||||
| 10/08/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: IMMUNOLOGY | ||||||
| 10/01/2024 | Organogenesis Inc. | MATRIX (Medical Supply) | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: WOUND CARE | ||||||
| 09/27/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $25.94 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 790 | 2,505 | $659,908 | $288,296 |
| 2022 | 11 | 272 | 703 | $146,358 | $35,314 |
| 2021 | 7 | 218 | 384 | $42,983 | $20,713 |
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| Q4194 | Novachor, per square centimeter | Office | 2023 | 14 | 235 | $242,650 | $189,767 | 78.2% |
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 26 | 33 | $64,379 | $16,118 | 25.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 104 | 188 | $62,512 | $15,994 | 25.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 67 | 118 | $44,966 | $11,501 | 25.6% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 22 | 33 | $40,149 | $10,736 | 26.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 71 | 71 | $35,468 | $8,370 | 23.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 62 | 100 | $26,915 | $6,886 | 25.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 109 | 1,228 | $23,739 | $6,281 | 26.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 110 | 209 | $41,429 | $6,117 | 14.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 80 | 115 | $34,171 | $5,422 | 15.9% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 48 | 88 | $13,077 | $3,498 | 26.8% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 13 | 20 | $10,630 | $2,838 | 26.7% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 18 | 19 | $9,508 | $2,282 | 24.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 24 | 24 | $8,075 | $2,045 | 25.3% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 11 | 13 | $2,202 | $430.67 | 19.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 11 | 11 | $35.75 | $9.35 | 26.2% |
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2022 | 13 | 17 | $34,123 | $6,924 | 20.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 44 | 44 | $22,286 | $5,603 | 25.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 23 | 41 | $15,740 | $4,309 | 27.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 26 | 34 | $11,461 | $3,099 | 27.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 26 | 41 | $11,181 | $3,066 | 27.4% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 19 | 21 | $10,548 | $2,915 | 27.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 30 | 43 | $12,982 | $2,882 | 22.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 27 | 362 | $7,146 | $1,972 | 27.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 30 | 49 | $9,776 | $1,676 | 17.1% |
About Dr. Simona Bartos, DO
Dr. Simona Bartos, DO is a MOHS-Micrographic Surgery healthcare provider based in Hollywood, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1174553846.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Simona Bartos, DO has received a total of $10,001 in payments from pharmaceutical and medical device companies, with $2,366 received in 2024. These payments were reported across 356 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($9,932).
As a Medicare-enrolled provider, Bartos has provided services to 1,280 Medicare beneficiaries, totaling 3,592 services with total Medicare billing of $344,323. Data is available for 3 years (2021–2023), covering 34 distinct procedure/service records.
Practice Information
- Specialty MOHS-Micrographic Surgery
- Other Specialties Dermatology
- Location Hollywood, FL
- Active Since 07/05/2006
- Last Updated 08/13/2024
- Taxonomy Code 207ND0101X
- Entity Type Individual
- NPI Number 1174553846
Products in Payments
- SKYRIZI (Biological) $905.34
- COSENTYX (Biological) $840.73
- DUPIXENT (Biological) $793.80
- Humira (Biological) $589.64
- RINVOQ (Biological) $451.75
- Puraply (Medical Supply) $385.02
- Tremfya (Drug) $363.79
- DUPIXENT DUPILUMAB INJECTION (Biological) $328.30
- TALTZ (Drug) $314.42
- HUMIRA (Biological) $311.99
- Skyrizi (Biological) $296.53
- CIBINQO (Drug) $292.76
- DUPIXENT (Drug) $278.74
- Otezla (Drug) $261.87
- ILUMYA (Biological) $252.38
- Erivedge (Biological) $229.56
- EUCRISA (Drug) $201.77
- ACTHAR (Biological) $194.25
- TREMFYA (Drug) $162.93
- VALCHLOR (Drug) $138.63
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.